Clinical Trial Update: Lemborexant on Improving Sleep Quality Among Hospital Rotating Shift Workers [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating lemborexant (Dayvigo) to improve sleep quality in hospital rotating shift workers; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Dayvigo (lemborexant)

Snippet

Sponsor: Phramongkutklao College of Medicine and Hospital | Conditions: Sleep | Phase 3 | Status: RECRUITING